ARCHIVES

Pfizer’s Withdrawal Of Mylotarg Signals Stronger FDA Resolve To Monitor Confirmatory Studies

This article is from The Cancer Letter archive.

Vol. 36 No. 24 | June 25, 2010

Download PDF Visit The Full Archive

Related Articles

Possible Budget Balancing Effort Darkens Prospect For Increase In Cancer Budget

March 7, 1980

NCI Launches M-PACT Next-Generation Trial As Group System Nears March 1 Transition

February 21, 2014

ODAC Oks Carboplatin As 1st Line Ovarian Therapy; Other Drugs

July 12, 1991

Consensus Panel Determines Total Mastectomy Plus Node Dissection “Satisfactory Alternative” To Radical Mastectomy

June 15, 1979

Advisors Approve Program To Link Radiation Oncologists.

June 29, 2001

Avastin Combination Approved For Metastatic Colorectal Cancer

February 22, 2013